Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus

• Type of Material: Article
• Authors: Ramiro Echeverry, Emory University; Jialing Wu, Emory University; Woldeab B. Haile, Emory University; Johanna Guzman, Emory University; Manuel Yepes, Emory University
• Language: English
• Date: 2010-06-01
• Publisher: American Society for Clinical Investigation
• Publication Version: Final Published Version
• Copyright Statement: © 2010, American Society for Clinical Investigation
• Final Published Version (URL): http://www.jci.org/articles/view/41722
• Title of Journal or Parent Work: Journal of Clinical Investigation
• ISSN: 0021-9738
• Volume: 120
• Issue: 6
• Start Page: 2194
• End Page: 2205
• Grant/Funding Information: This work was supported in part by NIH grants NS-062073 and HL-095063 (to M.Y.)
• Research Categories: Biology, Neuroscience

Abstract

The best-known function of the serine protease tissue-type plasminogen activator (tPA) is as a thrombolytic enzyme. However, it is also found in structures of the brain that are highly vulnerable to hypoxia-induced cell death, where its association with neuronal survival is poorly understood. Here, we have demonstrated that hippocampal areas of the mouse brain lacking tPA activity are more vulnerable to neuronal death following an ischemic insult. We found that sublethal hypoxia, which elicits tolerance to subsequent lethal hypoxic/ischemic injury in a natural process known as ischemic preconditioning (IPC), induced a rapid release of neuronal tPA. Treatment of hippocampal neurons with tPA induced tolerance against a lethal hypoxic insult applied either immediately following insult (early IPC) or 24 hours later (delayed IPC). tPA-induced early IPC was independent of the proteolytic activity of tPA and required the engagement of a member of the LDL receptor family. In contrast, tPA-induced delayed IPC required the proteolytic activity of tPA and was mediated by plasmin, the NMDA receptor, and PKB phosphorylation. We also found that IPC in vivo increased tPA activity in the cornu ammonis area 1 (CA1) layer and Akt phosphorylation in the hippocampus, as well as ischemic tolerance in wild-type but not tPA- or plasminogen-deficient mice. These data show that tPA can act as an endogenous neuroprotectant in the murine hippocampus.